tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ELDN Stock Latest News

Eledon Pharmaceuticals Reports Q3 2025 Financial Results
Company AnnouncementsEledon Pharmaceuticals Reports Q3 2025 Financial Results
1M ago
ELDN
Eledon Pharmaceuticals reports preliminary tegoprubart trial results
PremiumThe Fly
Eledon Pharmaceuticals reports preliminary tegoprubart trial results
1M ago
ELDN
Eledon Pharmaceuticals price target lowered to $8 from $9 at Guggenheim
PremiumThe Fly
Eledon Pharmaceuticals price target lowered to $8 from $9 at Guggenheim
1M ago
ELDN
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
PremiumRatings
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
1M ago
ELDN
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
PremiumThe Fly
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
1M ago
ELDN
Eledon Pharmaceuticals options imply 14.1% move in share price post-earnings
PremiumThe FlyEledon Pharmaceuticals options imply 14.1% move in share price post-earnings
1M ago
ELDN
Eledon Pharmaceuticals Announces $46.5M Public Offering
Premium
Company Announcements
Eledon Pharmaceuticals Announces $46.5M Public Offering
1M ago
8K
ELDN
Eledon prices 15.15M shares at $1.65 in underwritten public offering
Premium
The Fly
Eledon prices 15.15M shares at $1.65 in underwritten public offering
1M ago
ELDN
Eledon Pharmaceuticals announces common stock, warrant offering, no amount given
PremiumThe Fly
Eledon Pharmaceuticals announces common stock, warrant offering, no amount given
1M ago
ELDN
Eledon Pharmaceuticals options imply 8.0% move in share price post-earnings
PremiumThe Fly
Eledon Pharmaceuticals options imply 8.0% move in share price post-earnings
1M ago
ELDN
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
2M ago
HD
AMD
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
PremiumRatings
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
2M ago
ELDN
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
PremiumMarket NewsWhy Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
2M ago
ELDN
Eledon Pharmaceuticals Reports Promising Phase 2 Trial Results
Premium
Company Announcements
Eledon Pharmaceuticals Reports Promising Phase 2 Trial Results
2M ago
8K
ELDN
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart
Premium
Company Announcements
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart
2M ago
ELDN
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update
PremiumCompany Announcements
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update
2M ago
ELDN
Eledon Pharmaceuticals’ Tegoprubart: A Promising Buy Rating Amid Unmet Needs in Kidney Transplantation
PremiumRatings
Eledon Pharmaceuticals’ Tegoprubart: A Promising Buy Rating Amid Unmet Needs in Kidney Transplantation
4M ago
ELDN
Eledon Pharmaceuticals: Promising Developments and Strong Financial Outlook Justify Buy Rating
PremiumRatings
Eledon Pharmaceuticals: Promising Developments and Strong Financial Outlook Justify Buy Rating
4M ago
ELDN
Eledon Pharmaceuticals Advances in Transplant Trials
PremiumCompany Announcements
Eledon Pharmaceuticals Advances in Transplant Trials
4M ago
ELDN
Buy Rating for Eledon Pharmaceuticals: Promising Kidney Transplant Treatment and Strong Financial Position
PremiumRatingsBuy Rating for Eledon Pharmaceuticals: Promising Kidney Transplant Treatment and Strong Financial Position
4M ago
ELDN
Eledon Pharmaceuticals reports Q2 EPS (13c), consensus (23c)
Premium
The Fly
Eledon Pharmaceuticals reports Q2 EPS (13c), consensus (23c)
4M ago
ELDN
Positive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
Premium
Ratings
Positive Outlook for Eledon Pharmaceuticals Driven by Promising Tegoprubart Phase 1b Study Results
5M ago
ELDN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >